Tom Lee

Philip Morris International (Switzerland)

MedicineEngineeringImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia”.

Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia

Molecular Therapy(2021)10.1016/j.ymthe.2021.06.018

N/A

0DataRank · unranked

45 citations

Martin Felices, Frank Cichocki, Zachary Davis, Hongbo Wang, Katie Tuninga +7 more